U.S., Feb. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07399392) titled 'Radial Versus Femoral Secondary Access in Patients Undergoing TAVI' on Nov. 27, 2025.
Brief Summary: Severe symptomatic aortic stenosis (AS) with a high gradient is associated with a poor prognosis if not treated with valve replacement. Transcatheter aortic valve implantation has been shown in large randomized trials to be a safe and effective treatment option for patients at low, intermediate, or high risk. Transfemoral access for heart valve replacement is by far the most commonly used approach, as it is relatively easy to control and has a low complication rate compared to other access routes.
The TAVI procedure requires two art...